Investment Markets Information

Dow Stocks

The following is a list of the 30 stocks in the Dow Jones Industrial Average (D.J.I.A. or the "Dow). Year to date performance is included.

 

 Company

  Stock  Symbol

 %  change, year to date

 Intel

INTC

+31%

 Microsoft

 MSFT

+21%

 Caterpillar

CAT

 +20%

 Merck

MRK

+20%

 Walt  Disney

DIS

 +18%

 United Health  Group

UNH

 +15%

 Home Depot

HD

+13%

 Johnson &  Johnson  

JNJ

+13%

 Cisco  Systems

CSCO

+11%

 Travelers  Companies

TRV

 +5%

 Chevron Corp.

 CVX

+4%

 3M Co.

MMM

 +3%

 International Business  Machines

IBM

 +2%

 E I du pont

DD

 +2%

 Proctor & Gamble

PG

+2%

 JP Morgan

JPM

 +2%

 Verizon  Communications

VZ

 +1%

 The Coca-Cola Co.

KO

+1%

 Goldman Sachs

GS

 +1%

 Nike

NKE

0%

 AT &T

T

 -1%

 American Express

AXP

-1%

 Exxon Mobil

XOM

 -2%

 Wal-Mart

WMT

-4%

 McDonalds

MCD

-4%

 Pfizer Inc.

PFE

-4%

 United Technologies

UTX

-5%

 Visa

V

-5%

 Boeing

BA

-7%

 General Electric

GE

-7%

 Performance is rounded off

 

 Unbiased independent market analysis for investors who manage their own portfolio with a discount broker.

Stock market highlights

Heavy selling has been a characteristic of the U.S. equity markets for longer than many investors might realize. Today is no exception.

Charts for three stocks are shown below. A picture tells the story, revealing how downside power persists. The primary reason for heavy selling has been unacceptable earnings growth.

SeaWorld Goes On Deep Dive Mission

Former Tech. Leader Blasted Again

Bio-tech Suffers Significant Set Back

The bio-tech sector was hot for an unusually long period of time. But since the correction in the sector took hold, many have fallen by large amounts with tepid recovery attempts. For MYGN, today's decline is a decisive blow to the stock's attempt to advance a base, potentially setting up a new uptrend.

 

 

Unbiased independent market analysis for investors who manage their own portfolio.

 

How to use stock research

Investors and advisors use stock research to gain an understanding of a publicly traded company. Extensive examination of a company has been used for decades to serve investors in stock picking. But if using research reports for stocks is the right approach, then why isn’t it working better?

The most significant users of research reports is the investment industry itself. Investment Advisors routinely access research from multiple sources and use the research to form an opinion. Their opinion is the basis for a pitch to a client for a stock buy. But the problem is, it’s just an opinion and even if it’s good analysis, it doesn’t mean the stock buy is good timing. It’s essentially another form of speculation even though it is intended to avoid speculation. What matters in the stock market is timing and research reports rarely address stock behaviours and the market in general.

Almost all research reports are buy recommendations. It’s rare to find research describing why a stock is a sell. But if research was objective, there would be more stock coverage with a sell. Since 80% of all stocks fail to perform to the same degree as the top 20%, this should be the case, but it isn’t even close.

Advisors at large investment dealers satisfy the regulators by recommending stocks in big companies with research from their own firm. But does this work for investors? The research and the stock picks lack variety, objectivity and a thorough analysis of alternatives.

Research Reports Fail To Deliver

If investors want their portfolio to succeed, they’d be better off ignoring most research reports. Our studies have shown that the most significant fundamental measure in the stock market is earnings and sales growth. That information takes only minutes to determine and it’s free. Other fundamental measures have not proven to be significant enough to impact the stock screening process.

Since 2012, earnings and sales growth has been profoundly important for avoiding down trends in most stocks. But other indicators have been the key to picking stocks for outperformance.

Avoiding research reports helps investors maintain objectivity in order to target factors that matter in the management of a stock portfolio.

 

Unbiased independent market analysis for investors who want to know how to do better.

Stock selling rampant

Until recently, most stock averages had been going higher. But heavy selling has been hitting many stocks for months and it's becoming rampant.

Three examples are provided below showing the last six months of price and volume action from their stock charts. It would be easy to dismiss this as just one day in the market, but it hasn't been unusual. Investors may follow the selling on a day by day basis, as our research does, using data lists such as the percentage and price decliners lists.

The decliners list for August 6, 2014 is directly below. There are a considerable number of better quality company stocks suffering large losses. Compare it to the gainers lists and a significant aberration is obvious.

 

 

 

Unbiased independent market analysis with strategies and execution tips for investors.

For contact; info@investorbootcamponline.com

View Archive

Commentary including ideas, historical and other market indications are not investment advice. Statistics and other data may be from other sources and may be inaccurate or incomplete. See Full Disclaimer.

The market is the news!

 

emailEmail this to a friend

HOME | WHO WE ARE | WHAT WE DO | INVESTMENT INSIGHTS | FAQS | SUBSCRIBE

PRIVACY POLICY | TERMS | DISCLAIMER | SITEMAP | CONTACT

COPYRIGHT 2009 INVESTOR BOOT CAMP ONLINE